Latest Breaking News On - Salim syed - Page 1 : comparemela.com

Investors say 'no bueno' to Cytokinetics' complex Royalty deal

Cytokinetics has now all but assured that a buyout is not happening with a $575 million Royalty Pharma funding deal that drew the ire of investors.

Wave Life Sciences Ltd. (NASDAQ:WVE) Q1 2024 Earnings Call Transcript

Investors Pile Into Amgen in Search of Next Obesity Drug Payout

(Bloomberg) Investors who may have missed out on the blistering rally in Eli Lilly & Co. and Novo Nordisk A/S are once again taking a chance with Amgen Inc.Most Read from BloombergTruce Talks Drag as Hamas Hits Israel Crossing in Deadly AttackBuffett Praises Apple After Trimming It, Drops Paramount StakeTreasury Rally Risks Running Into a $125 Billion Brick WallFrance’s Macron Calls for Reset of Economic Ties With ChinaLamborghini Bros No More: Crypto Is Creating a New Wealth EffectThe shares

Amgen shares jump after teasing weight-loss drug data, rivals slip

-U.S. drugmaker Amgen s shares jumped 14% premarket on Friday as the company said it was encouraged by interim trial data on its experimental obesity drug, denting rival stocks but. -May 03, 2024 at 06:16 am EDT - MarketScreener

Pfizer Stock Jumps On 'Massive' First-Quarter Upside Thanks To Paxlovid Surprise